How to read an FDA De Novo classification order

Most devices reach the market by pointing to something already legally sold and claiming to be substantially equivalent to it. A device with no legitimate predicate cannot make that claim — and for a genuinely novel, low-to-moderate-risk device, De Novo classification is the pathway that exists to solve exactly that problem. Reading the order FDA issues when it grants one is worth doing before you ever rely on it, because a De Novo order does something a 510(k) clearance letter does not: it creates the very device type the next sponsor will search for.

Why the pathway exists

FDA's device classification scheme assumes a new device usually resembles something already on the market. When that assumption fails — a device is genuinely novel, with no predicate to compare it against — the default outcome of a 510(k) is a finding of not substantially equivalent, which pushes the device into Class III by operation of law and would otherwise require an approved PMA regardless of how modest its actual risk is. De Novo exists to correct that mismatch: it lets FDA classify a novel device into Class I or II directly, on the strength of general controls and, where needed, device-specific special controls, without forcing a low-to-moderate-risk device through the PMA process it does not need.

What’s actually in the order

A granted De Novo order carries a DEN number in place of a 510(k) number, the device’s name and generic type, the order date, and — the part worth reading closely — the regulation number and product code FDA is newly establishing for that device type, along with an indications for use statement and the specific list of special controls being imposed in place of a predicate comparison. That structure is a deliberate departure from a 510(k) decision summary: there is no substantial-equivalence discussion, because there is no predicate to be equivalent to. What replaces it is the special controls list, which functions as the safety-and-effectiveness case for the entire device type going forward, not just for your specific submission.

The predicate you just created

Once granted, a De Novo-cleared device becomes a legally marketed device in its own right, which means a later sponsor can cite it as the predicate for a 510(k) of the same type. That is a genuine strategic consideration, not a footnote: a De Novo grant does not just clear your device, it opens a faster on-ramp — the ordinary 510(k) pathway — for whoever wants to enter the category after you. Sponsors who treat a De Novo grant purely as a finish line sometimes miss that it also starts a clock on how long they have the category to themselves.

Reading a De Novo order well means reading it the same way you would read your own eventual 510(k): looking for what it actually establishes, not just what it approves. If you are coming into this work from a research background, that instinct — reading precisely for what a document supports, not what it implies — is the same one worth demonstrating on the way in.